as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹115.55
Change
-0.22 (-0.19%)
Open
₹115.88
Prev. Close
₹115.77
Day High
₹118.49
Day Low
₹115.05
Volume Analysis
Traded
61,474
Delivered
36,186
Delivery %
58.86%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (1)
- •Low return on equity (9.51%)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹121.11 | ₹119.8 | ₹117.67 | ₹116.36 | ₹114.23 | ₹112.92 | ₹110.79 |
| Fibonacci | ₹119.8 | ₹118.49 | ₹117.67 | ₹116.36 | ₹115.05 | ₹114.23 | ₹112.92 |
| Camarilla | ₹116.5 | ₹116.18 | ₹115.87 | ₹116.36 | ₹115.23 | ₹114.92 | ₹114.6 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-3.88%
1 Week
-2.99%
1 Month
-7.14%
3 Months
-33.41%
6 Months
+4.31%
1 Year
-12.89%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹65.89
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
9.44%
Net margin 9.0% × asset turnover 0.86x × equity multiplier 1.22x
Company Overview
Sector
Capital Goods
Market Cap
₹1,050 Cr
P/E (TTM)
23.6
ROE
9.51%
Book Value
₹49.6
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.
TopFund Analysis
Borosil Scientific Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Capital Goods sector, at 55/100. The strongest factor is Financial Strength (100/100), while Momentum (25/100) is the weakest area to weigh before deciding. Notably: Low return on equity (9.51%).
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- +Company is almost debt free.
- +Company's working capital requirements have reduced from 112 days to 84.0 days
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has a low return on equity of 7.61% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Borosil Scientific approved Bharuch facility expansion from 15 to 108 lakh units annually; Rs. 60 crore capex, by March 2027.
Newspaper Advertisements - Electronic dispatch of Annual Report for FY 2025-26 including the Notice of 35th Annual General Meeting
35th AGM on September 25, 2026; annual report FY2025-26 and e-voting details shared.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 88 | 92 | 100 | 116 | 104 | 103 | 101 | 129 | 96 | 107 | 121 | 143 | 107 |
| Expenses + | 82 | 83 | 88 | 97 | 94 | 87 | 91 | 113 | 91 | 99 | 104 | 111 | 98 |
| Operating Profit | 6 | 9 | 12 | 18 | 10 | 16 | 10 | 17 | 5 | 8 | 17 | 32 | 8 |
| OPM % | 6.53% | 10.3% | 12.19% | 15.79% | 9.43% | 15.36% | 9.87% | 12.8% | 5.06% | 7.51% | 14.17% | 22.43% | 7.92% |
| Other Income + | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | -4 | 2 | 1 | 2 | 3 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 4 | 4 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | 2 | 6 | 8 | 15 | 7 | 12 | 7 | 14 | -4 | 5 | 13 | 29 | 6 |
| Tax % | -35.54% | 20.22% | 30.48% | 35.27% | 28.49% | 29.09% | 38.33% | 38.52% | 3.18% | 44.36% | 31.25% | 6.52% | 27.09% |
| Net Profit + | 3 | 5 | 6 | 9 | 5 | 9 | 4 | 9 | -4 | 3 | 9 | 27 | 4 |
| EPS in Rs | — | — | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 3 | 0 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales + | 392 | 434 | 462 | 478 |
| Expenses + | 345 | 381 | 400 | 412 |
| Operating Profit | 47 | 53 | 63 | 66 |
| OPM % | 12.0% | 12.0% | 14.0% | 14.0% |
| Other Income + | 4 | 8 | 0 | 7 |
| Interest | 3 | 2 | 1 | 1 |
| Depreciation | 16 | 18 | 19 | 19 |
| Profit before tax | 32 | 40 | 43 | 53 |
| Tax % | 26.0% | 34.0% | 19.0% | — |
| Net Profit + | 23 | 27 | 35 | 43 |
| EPS in Rs | 3 | 3 | 4 | 5 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Reserves | 367 | 395 | 432 |
| Borrowings + | 18 | 14 | 9 |
| Other Liabilities + | 95 | 86 | 90 |
| Total Liabilities | 488 | 504 | 540 |
| Fixed Assets + | 192 | 187 | 189 |
| CWIP | 1 | 1 | 9 |
| Investments | 0 | 105 | 122 |
| Other Assets + | 295 | 210 | 220 |
| Total Assets | 488 | 504 | 540 |
| Equity Capital | 9 | 9 | 9 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity + | 30 | 120 | 43 |
| Cash from Investing Activity + | -2 | -115 | -37 |
| Cash from Financing Activity + | -16 | -3 | -6 |
| Net Cash Flow | 12 | 1 | 0 |
| CFO/OP | 97 | 249 | 92 |
| Free Cash Flow | 17 | 106 | 16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Public | 31.54% | 31.74% | 31.88% | 31.91% | 31.93% | 32.03% | 31.93% | 31.57% | 31.22% |
| Promoters | 67.92% | 67.86% | 67.84% | 67.81% | 67.8% | 67.8% | 67.8% | 68.08% | 68.27% |
| FII | 0.38% | 0.37% | 0.27% | 0.24% | 0.2% | 0.07% | 0.07% | 0.09% | 0.23% |
| DII | 0.15% | 0.01% | 0.02% | 0.02% | 0.05% | 0.1% | 0.19% | 0.26% | 0.26% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Capital Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Borosil Scientific Ltd (this stock) | 1,050 | 23.6 | 2.38 | 9.51% |
| Grp Limited | 1,060 | 155.0 | 5.95 | 2.48% |
| Nelcast Limited | 1,030 | 25.1 | 1.72 | 8.43% |
| Dhunseri Ventures Limited | 1,028 | 5.39 | 0.31 | 4.86% |
| Mic Electronics Ltd | 1,075 | — | 4.02 | -5.76% |
| Jyoti Structures Ltd | 1,080 | 16.8 | 2.28 | 10.8% |
| Tembo Global Ind Ltd | 1,081 | 10.6 | 2.39 | 27.5% |
Which Mutual Funds Hold Borosil Scientific Ltd?
Frequently Asked Questions about Borosil Scientific Ltd
Borosil Scientific Ltd (BOROSCI) closed at ₹115.55 on NSE on 25 September 2026, down 0.22 (0.19%) from the previous close.
Borosil Scientific Ltd trades on the NSE (National Stock Exchange of India) under the symbol BOROSCI.
Borosil Scientific Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 23.6.
Borosil Scientific Ltd has a dividend yield of 0.0%.
Borosil Scientific Ltd's 52-week high is ₹181.0 and its 52-week low is ₹96.6.
Borosil Scientific Ltd has a market capitalisation of ₹1,050 crore.
Borosil Scientific Ltd has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Borosil Scientific Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.